Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05160012 · ClinicalTrials.gov registry record · NA
Peer Comparison Feedback to Providers to Improve Hypertension Control
A NA study of Hypertension, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT05160012: Active NA study of Hypertension, sponsored by University of Pennsylvania.
NCT05160012 is a NA study of Hypertension that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 93 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05160012, a NA study of Hypertension, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
As part of a roll out of new payment model for physicians based on hypertension control, the investigators will evaluate a monthly peer comparison message to Primary Care Providers at Penn Medicine Lancaster to see whether provider engagement with patients' overall hypertension management increases, as measured by new or increasing doses of anti-hypertensive medications.
Conditions Studied
Interventions
- BEHAVIORAL Peer Comparison Message
Study Locations (1)
Pennsylvania
- Lancaster General Hospital - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2022-04-05 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05160012
The ClinicalTrials.gov registry entry for NCT05160012 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Peer Comparison Message is the first listed.
NCT05160012 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05160012 about?
NCT05160012 is a clinical study titled "Peer Comparison Feedback to Providers to Improve Hypertension Control". As part of a roll out of new payment model for physicians based on hypertension control, the investigators will evaluate a monthly peer comparison message to Primary Care Providers at Penn Medicine Lancaster to see whether provider engagement with patients' overall hypertension management increases,...
What is the current status of trial NCT05160012?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 93 participants. The study started on 2022-04-05. Estimated completion is 2026-04.
What conditions does trial NCT05160012 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT05160012?
The interventions under investigation include: Peer Comparison Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05160012?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05160012 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.